The Female Health Company to Present at Sidoti Micro Cap Conference

Jun 17, 2010, 08:30 ET from The Female Health Company

CHICAGO, June 17 /PRNewswire-FirstCall/ -- The Female Health Company (Nasdaq: FHCO), which manufactures and markets the FC2 Female Condom®, today announced that O.B. Parrish, CEO, and Donna Felch, CFO, are scheduled to make a presentation at the Sidoti Micro Cap Conference at 11:20 AM Eastern Time on Friday, June 25, 2010. The Company's executives will also meet with investors to discuss the Company's ongoing operations. The conference will be held at the Grand Hyatt Hotel in New York City.

About Sidoti & Company, LLC

Sidoti & Company, LLC is the largest and fastest-growing small-cap equity research provider on Wall Street. Its analysts provide institutional-quality research on nearly 600 companies across more than 30 industries, focusing on profitable, undiscovered companies with market capitalizations below $3 billion.

About The Female Health Company

The Female Health Company, based in Chicago, Illinois, manufactures and markets the FC2 Female Condom® (FC2), which is available in the U.S. and about 100 countries around the world. The Company owns certain worldwide rights to the FC2 Female Condom®, including patents that have been issued in the U.S., Europe, Canada, Australia, South Africa, Japan, Spain, Greece and Turkey and pending in various countries. The FC2 Female Condom® is the only available FDA-approved product controlled by a woman that offers dual protection against sexually transmitted diseases, including HIV/AIDS, and unintended pregnancy. The World Health Organization (WHO) has cleared FC2 for purchase by U.N. agencies.

"Safe Harbor" statement under the Private Securities Litigation Reform Act of 1995:

The statements in this release which are not historical facts are forward-looking statements based upon the Company's current plans and strategies, and reflect the Company's current assessment of the risks and uncertainties related to its business, including such things as product demand and market acceptance; the economic and business environment and the impact of government pressures; currency risks; capacity; efficiency and supply constraints; and other risks detailed in the Company's press releases, shareholder communications and Securities and Exchanges Commission filings. Actual events affecting the Company and the impact of such events on the Company's operations may vary from this currently anticipated.

For more information about the Female Health Company visit the Company's website at and If you would like to be added to the Company's e-mail alert list, please send an e-mail to

SOURCE The Female Health Company